2.87
price down icon2.71%   -0.08
after-market Handel nachbörslich: 2.87
loading

Xbiotech Inc Aktie (XBIT) Neueste Nachrichten

pulisher
12:09 PM

XBiotech Inc. (NASDAQ:XBIT) Short Interest Down 23.1% in March - MarketBeat

12:09 PM
pulisher
Apr 01, 2025

XBiotech Announces Board Member Retirement - TipRanks

Apr 01, 2025
pulisher
Mar 29, 2025

XBiotech (NASDAQ:XBIT) Share Price Crosses Above 50-Day Moving AverageHere's Why - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

Bank of New York Mellon Corp Has $360,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Mar 29, 2025
pulisher
Mar 29, 2025

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc. -- XBIT - ACCESS Newswire

Mar 29, 2025
pulisher
Mar 23, 2025

XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results - MarketBeat

Mar 23, 2025
pulisher
Mar 14, 2025

Stocks Recover Some of This Week’s Losses as US Shutdown Seems Averted - TradingView

Mar 14, 2025
pulisher
Mar 14, 2025

Stocks Rally as US Government Shutdown Risks Recede - TradingView

Mar 14, 2025
pulisher
Mar 13, 2025

Tariff Worries Pressure Stocks - TradingView

Mar 13, 2025
pulisher
Mar 02, 2025

XBiotech Inc.'s (NASDAQ:XBIT) 18% gain last week benefited both retail investors who own 49% as well as insiders - Simply Wall St

Mar 02, 2025
pulisher
Feb 28, 2025

XBIT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of XBiotech Inc. Shareholders Who Lost Money - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against XBiotech, Inc. (XBIT) and Lead Plaintiff Deadline: February 1, 2016 - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 20, 2025

Investor Network: XBiotech, Inc. to Host Earnings Call - ACCESS Newswire

Feb 20, 2025
pulisher
Feb 20, 2025

XBiotech Inc. (NASDAQ:XBIT) Sees Large Growth in Short Interest - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Head to Head Contrast: Aurinia Pharmaceuticals (NASDAQ:AUPH) and XBiotech (NASDAQ:XBIT) - Armenian Reporter

Feb 20, 2025
pulisher
Feb 18, 2025

XBiotech stock plunges to 52-week low, touches $3.03 - Investing.com India

Feb 18, 2025
pulisher
Feb 18, 2025

XBiotech stock plunges to 52-week low, touches $3.03 By Investing.com - Investing.com Canada

Feb 18, 2025
pulisher
Feb 18, 2025

Head-To-Head Analysis: Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. XBiotech (NASDAQ:XBIT) - Defense World

Feb 18, 2025
pulisher
Feb 17, 2025

Investing in XBiotech Inc (XBIT) might be a great opportunity, but the stock is a bit overvalued - US Post News

Feb 17, 2025
pulisher
Feb 16, 2025

XBiotech Inc. (NASDAQ:XBIT) Short Interest Update - Defense World

Feb 16, 2025
pulisher
Feb 07, 2025

XBIT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into XBiotech Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire

Feb 07, 2025
pulisher
Feb 04, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire

Feb 04, 2025
pulisher
Jan 30, 2025

XBiotech stock hits 52-week low at $3.5 amid market challenges - MSN

Jan 30, 2025
pulisher
Jan 27, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Shareholders to Connect - Markets Insider

Jan 27, 2025
pulisher
Jan 27, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Shareholders to Reach Out - Markets Insider

Jan 27, 2025
pulisher
Jan 23, 2025

XBiotech Inc. (XBIT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider

Jan 23, 2025
pulisher
Jan 22, 2025

Barclays PLC Boosts Stock Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Stockholders to Inquire about Securities Investigation - Markets Insider

Jan 21, 2025
pulisher
Jan 18, 2025

XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm - Kilgore News Herald

Jan 18, 2025
pulisher
Jan 15, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Stockholders to Reach Out - Markets Insider

Jan 15, 2025
pulisher
Jan 15, 2025

Jane Street Group LLC Acquires Shares of 11,141 XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

Wolf Haldenstein Adler Freeman & Herz LLP announces that it - GlobeNewswire

Jan 14, 2025
pulisher
Jan 14, 2025

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws - GlobeNewswire Inc.

Jan 14, 2025
pulisher
Jan 10, 2025

XBiotech Inc.'s (NASDAQ:XBIT) largest shareholders are individual investors with 49% ownership, insiders own 35% - Yahoo Finance

Jan 10, 2025
pulisher
Jan 07, 2025

Geode Capital Management LLC Acquires 22,059 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 07, 2025
pulisher
Jan 07, 2025

Barclays PLC Acquires 18,761 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 07, 2025
pulisher
Jan 02, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc.VKTX - PR Newswire

Jan 02, 2025
pulisher
Jan 02, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Walmart Inc.WMT - PR Newswire

Jan 02, 2025
pulisher
Jan 02, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire

Jan 02, 2025
pulisher
Jan 02, 2025

State Street Corp Grows Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

XBiotech Inc. Appoints Dr. Tak W. Mak to its Board of Directors - Defense World

Jan 02, 2025
pulisher
Dec 31, 2024

XBiotech Appoints Renowned Scientist to Board of Directors - TipRanks

Dec 31, 2024
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):